Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response
Abstract Acquired or innate lack of response to standard HER2-targeted therapies remains a clinical issue in patients with HER2-positive breast…
Abstract Acquired or innate lack of response to standard HER2-targeted therapies remains a clinical issue in patients with HER2-positive breast…
Abstract Healthy individuals that use cannabis are at greater risk of developing mental health conditions than those that do not…
Abstract Cigarette smoking is a major preventable cause of morbidity and mortality. While quitting smoking is the best option, switching…
Abstract The pandemic caused by SARS-CoV-2 impacted health systems globally, creating increased workload and mental stress upon health care workers…
Abstract Despite the benefits associated with longer buprenorphine treatment duration (i.e., >180 days) (BTD) for opioid use disorder (OUD), retention…
Abstract Cannabis is widely used worldwide, yet its links to health outcomes are not fully understood. DNA methylation can serve…
Abstract The primary cannabinoid in cannabis, Δ9-tetrahydrocannabinol (THC), causes intoxication and impaired function, with implications for traffic, workplace, and other…
Abstract Anhedonia and amotivation are debilitating symptoms and represent unmet therapeutic needs in a range of clinical conditions. The gut-microbiome-endocannabinoid…
Abstract Anxiety- and trauma-related disorders are severe illnesses with high prevalence. Current treatment options leave room for improvement and the…
Abstract Autism spectrum disorder (ASD) is a high cost neurodevelopmental condition; and there are currently no effective pharmacological treatments for…